Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Rodent studies have found it to be about 2.5 times more anabolic muscle-building than IGF-1 (11)
Most insurance plans cover GLP-1 medications only when prescribed for diabetes or, in some cases, obesity with specific BMI criteria
Rare but serious gastrointestinal complications have been reported in post-marketing surveillance, including: Acute pancreatitis : If suspected, the GLP-1 agonist should be stopped immediately and not restarted if pancreatitis is confirmed Severe gastroparesis : Rare post-marketing reports of severe delayed gastric emptying Intestinal obstruction : Very rare cases reported in post-marketing surveillance Patients should be advised to seek urgent medical help via NHS 111, A&E or 999 as appropriate if they experience severe or persistent abdominal pain, persistent vomiting, abdominal distension, inability to pass stool or gas, or bloody diarrhoea whilst taking GLP-1 agonists
Take 1 vial (60 ml) once daily
Gut/GI protection Explored in preclinical research on protection of the gastrointestinal tract, reflecting its origin in a protein found in gastric juice
Repeat: patients typically run 2 to 3 full cycles per year
US$ 27.85
US$ 28.20
US$ 29.87
